MARKET NOTES / 001INDIA / BENGALURU / LIFE SCIENCES
LESS GUESSWORK. A BETTER RESEARCH LIST.

Life Sciences.
Bengaluru.

Map the capital.
Find your next conversation.

Who backs this market, where they enter, and how recently they have added a new company. A directory built around the questions founders actually ask.

Build your research shortlist ↘
Companies are based in Bengaluru · investors can be based anywhere
Dataset through 22 May 2026 · calculated 14 Sep 2026
01 / THE SHORTLIST LAB

Make the list work for your company.

53 backers based in Bengaluru are shown by default. Compare up to three.

53 of 319 selected backers · Bengaluru only

Shows investors whose recorded city is Bengaluru. Unknown cities are excluded. Market charts cover all investor locations.

Theme filtering selects backers of companies carrying that theme tag. Entry-stage filtering selects backers with an entry at that stage; the two matches may be different companies. Row metrics describe their entire dated Life Sciences history in Bengaluru.

Selected investors ranked by distinct companies backed, with first-entry financing and recent activity.
CompareInvestor / recorded locationCompanies
here
New in
24 months
Median total
entry round
Companies
backed again
Latest
investment
Loading investors…
THE INVESTOR, IN CONTEXT
LINKEDIN ACCESS

Continue with Radar

Sign in to Radar to continue researching this investor.

Sign in to Radar ↗
02 / THE MARKET READ

Activity is a better starting point
than a long list of names.

Latest 24 months: after 22 May 2024 through 22 May 2026.

RECENT PARTICIPATION
259

Backers in a recent round

227 added at least one new company in this market. The remainder participated only in companies they had already backed here.

Explore recently active backers ↗
MARKET PACE
61

Distinct equity rounds

Across 38 companies, versus 66 rounds in the preceding 24 months. Each company round is counted once.

See the recent evidence ↗
EARLY FINANCING
62.3%

Rounds at Angel, Pre-Seed or Seed

38 of 61 recent rounds. Compare your stage with its own financing range before sizing the ask.

Compare stage ranges ↗
NEW RELATIONSHIPS
81%

Participations were first entries

233 first investor–company relationships out of 289 participations. The other 56 were later rounds together.

Find backers adding companies ↗

Build a syndicate beyond the city.

Of 259 recently active backers, 29 have a recorded Bengaluru location and 75 are based elsewhere. Location is missing for 155. Search by market experience first, then investigate the people and their remit.

Match the whole round to your plan.

Recent Seed rounds have a median size of $299K, across 27 disclosed amounts. That is total company financing. An individual investor’s cheque or available capital is not disclosed here.

03 / EMERGING THEMES

Which themes are gaining share?

Follow financing activity across the company classifications represented in this market.

Latest four complete quarters: 01 Apr 2025–31 Mar 2026 · 27 market rounds, versus 38 in the preceding four quarters.

LOSING SHARE

Dpiit Registered

-33.9 pp

15 of 27 recent rounds (55.6%), versus 34 of 38 (89.5%).

LOSING SHARE

Medical Devices

-9.8 pp

8 of 27 recent rounds (29.6%), versus 15 of 38 (39.5%).

LATEST DETECTED SPIKE

Deep Tech

20.0%

3 of 15 rounds in Q3 2024, compared with 10.8% over the prior four quarters.

GAINING SHARE

Genomics

+10.1 pp

7 of 27 recent rounds (25.9%), versus 6 of 38 (15.8%).

SPIKE DETECTION

Look beyond the headline total.

Share of market roundsPrior four-quarter shareDetected spike

Scroll sideways to explore all quarters.

Enterprise Software: quarterly share of recorded equity roundsSolid line: share of market rounds. Dashed line: share over the previous four complete quarters. Rings mark rule-based spikes. Shading marks a partial quarter, excluded from detection. 0%12.5%25%37.5%50% Partial 2020Q1 2020: 2 / 12 rounds, 16.67%Q2 2020: 1 / 13 rounds, 7.69%Q3 2020: 5 / 12 rounds, 41.67%Q4 2020: 1 / 12 rounds, 8.33%2021Q1 2021: 1 / 11 rounds, 9.09%Q2 2021: 1 / 12 rounds, 8.33%Q3 2021: 1 / 8 rounds, 12.5%Q4 2021: 5 / 12 rounds, 41.67%2022Q1 2022: 3 / 7 rounds, 42.86%Q2 2022: 1 / 9 rounds, 11.11%Q3 2022: 1 / 9 rounds, 11.11%Q4 2022: 1 / 8 rounds, 12.5%2023Q1 2023: 2 / 6 rounds, 33.33%Q2 2023: 0 / 8 rounds, 0%Q3 2023: 3 / 8 rounds, 37.5%Q4 2023: 3 / 9 rounds, 33.33%2024Q1 2024: 3 / 11 rounds, 27.27%Q2 2024: 1 / 9 rounds, 11.11%Q3 2024: 2 / 15 rounds, 13.33%Q4 2024: 1 / 8 rounds, 12.5%2025Q1 2025: 1 / 6 rounds, 16.67%Q2 2025: 0 / 4 rounds, 0%Q3 2025: 1 / 7 rounds, 14.29%Q4 2025: 4 / 11 rounds, 36.36%2026Q1 2026: 1 / 5 rounds, 20%

Q4 2025 · 4 of 11 market rounds · 4 companies · 36.4% share. A detected spike, 3.03× the prior four-quarter share.

Select a dot to inspect the exact count and baseline. The partial quarter through 22 May 2026 is shown but cannot trigger a spike.

The theme shift, year by year.

Share of all recorded Life Sciences rounds in Bengaluru. Each cell also gives its theme-round count.

Theme shares and round counts by calendar year. 2026 is partial through 22 May 2026.
Investment theme2020202120222023202420252026*
65.3%32 / 4965.1%28 / 4387.9%29 / 3374.2%23 / 3186.1%37 / 4367.9%19 / 2840.0%2 / 5
34.7%17 / 4939.5%17 / 4333.3%11 / 3335.5%11 / 3139.5%17 / 4328.6%8 / 2840.0%2 / 5
10.2%5 / 4911.6%5 / 4318.2%6 / 3312.9%4 / 3116.3%7 / 4325.0%7 / 2840.0%2 / 5
10.2%5 / 497.0%3 / 4312.1%4 / 336.5%2 / 3111.6%5 / 4325.0%7 / 2820.0%1 / 5
24.5%12 / 4914.0%6 / 436.1%2 / 3322.6%7 / 3116.3%7 / 437.1%2 / 2820.0%1 / 5
18.4%9 / 4918.6%8 / 4318.2%6 / 3325.8%8 / 3116.3%7 / 4321.4%6 / 2820.0%1 / 5
22.5%11 / 4911.6%5 / 4324.2%8 / 3319.4%6 / 3116.3%7 / 4314.3%4 / 2820.0%1 / 5
8.2%4 / 4920.9%9 / 436.1%2 / 3316.1%5 / 3120.9%9 / 4310.7%3 / 2820.0%1 / 5

*2026 is partial. Company themes use the tags available in this dataset, applied to historical rounds; they do not date when a business adopted a technology. Themes overlap, so shares do not add to 100%. Each company round is counted once within a theme. These charts cover investors from all locations; the shortlist keeps its own location filter.

How a spike is detected

A complete quarter is flagged when its theme share is at least 1.75× the share across the preceding four quarters and at least 5 percentage points higher. It must contain at least 3 theme rounds across 3 companies, at least 10 market rounds, and at least 3 theme rounds in the baseline. All four baseline quarters must have market observations. A zero baseline, missing observations or partial quarter cannot produce a flag.

This is a transparent screening rule, not a statistical significance test or a forecast. A higher share can accompany fewer rounds when the wider market contracts; the counts beside the chart make that distinction visible.

04 / THE DEPTH MAP

One appearance, or a pattern?

1,254 of 1,342 backers with dated histories appear in just one company. Select a cell to explore the directory.

Backers by type and number of distinct Life Sciences companies backed in Bengaluru, all dated history.
Portfolio breadth here1 company2 companies3–56–1011+
Firms & institutions
Individual angels

Circle area increases with backer count. The shortlist includes backers with 2 or more companies in this market, plus other backers active in the latest 24 months. In the 1-company cell, only recently active backers are available to explore. The shortlist’s investor-location filter also applies; select all locations to broaden the results. 0 backers have only undated entries.

05 / ROUND DESIGN

Different stages. Different capital.

Recent equity rounds · 24-month window.
Amounts are in USD.

StageDistinct roundsMedian / middle half
Angel
9
$166K$111K–$772K9 disclosed
Seed
29
$299K$109K–$968K27 disclosed
Series A
13
$3.4M$2.2M–$6.0M12 disclosed
Series B
6
$10M$9.8M–$18M5 disclosed
Series C
2
$7.0M$5.4M–$8.5M2 disclosed · small sample
Series D
1
$28M$28M–$28M1 disclosed · small sample
Series E+
1
$48M$48M–$48M1 disclosed · small sample
06 / FOLLOW THE EVIDENCE

The most recent recorded rounds.

Distinct company rounds.
Named backers are shown lead-first.

Series B

Developer of regenerative medicine and 3D tissues

$429K total equity round
1 named backer

We Founder Circle

Seed

Developer of robotic systems for surgical procedures

Undisclosed total equity round
1 named backer

Kalaari Capital

Series B

Provider of precision oncology solutions, including genomic testing and digital health

$9.8M total equity round
3 named backers

Ashish Kacholia · Lashit Sanghvi · Yali Capital

Seed

Retailer of supplements formulated for sleep, gut health, and immunity

$608K total equity round
10 named backers

Huddle Ventures · OTP Ventures · Ishita Jain · Kapil Bharati · Mohit Kumar · +5 more

Angel

Developer of neuromodulation therapy designed to help relearn natural movement

$111K total equity round
3 named backers

Kunal Bahl · Namita Thapar · Vineeta Tejpal Singh

Series A

Provider of AI-based proteomic data analysis software for drug discovery

$7.7M total equity round
9 named backers

Indian Angel Network Fund · Speciale Invest · Anandi Krishnan · Anjali Panakkat · BYT Capital · +4 more

07 / READING THE ATLAS

What these patterns can tell you.

The market boundary

Recorded equity rounds for companies tagged Life Sciences and located in Bengaluru. Investor headquarters may be elsewhere. Company sector and location reflect the available company records, not necessarily the location or sector at the investment date.

The time boundary

Data coverage ends 22 May 2026. The latest market round is 20 Mar 2026. There are 1 undated participations, excluded from timing metrics. Activity after the cutoff is unknown.

The relationship boundary

“New” is the first dated relationship between a backer and a company in this market. “Backed again” requires a later dated round together. A first observed entry may follow an earlier unrecorded investment.

The financing boundary

Amounts describe entire equity rounds, not personal cheques, fund capacity or returns. Medians exclude missing and non-positive amounts; the middle half spans the 25th–75th percentiles. A recorded investment does not establish current availability.

RADAR / COMPANY DISCOVERY

Find the businesses
worth a closer look.

Search Bengaluru Life Sciences companies in Radar. Filter the company directory to explore the businesses behind your market and investor research.

Explore companies in Radar ↗
FLIAR / CUSTOM DASHBOARD SERVICE

A research dashboard.
Built for your company.

We build customized research dashboards for companies. Tell us which competitors, markets and questions matter to your team, and discuss a dashboard designed around your needs.

Discuss a custom dashboard ↗A customized service from Fliar. Contact us to discuss your requirements.
FLIAR PRISM / RESEARCH TOOL

Turn your questions
into deeper research.

Use Fliar Prism to research a company, market or topic, with reports and insights drawn from its research dataset.

Explore Fliar Prism ↗Start with the company or question you want to understand.

Calculated 14 Sep 2026 · 319 investor histories to explore